Sudbø J - Search Results

1

Novel management of oral cancer: a paradigm of predictive oncology.

Sudbø J. Sudbø J. Clin Med Res. 2004 Nov;2(4):233-42. doi: 10.3121/cmr.2.4.233. Clin Med Res. 2004. Retraction in: Clin Med Res. 2007 Oct;5(3):203. doi: 10.3121/cmr.2004.587.retraction PMID: 15931363 Free PMC article. Retracted. Review.

2

The evolution of predictive oncology and molecular-based therapy for oral cancer prevention.

Sudbø J, Reith A. Sudbø J, et al. Int J Cancer. 2005 Jun 20;115(3):339-45. doi: 10.1002/ijc.20896. Int J Cancer. 2005. PMID: 15688375 Review.

3

Molecular based treatment of oral cancer.

Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM. Sudbø J, et al. Oral Oncol. 2003 Dec;39(8):749-58. doi: 10.1016/s1368-8375(03)00098-8. Oral Oncol. 2003. Retraction in: Oral Oncol. 2007 Apr;43(4):421. doi: 10.1016/j.oraloncology.2007.01.004 PMID: 13679198 Retracted. Review.

4

Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling.

Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R, Sigstad E, Davidson B, Reith A, Berner A. Sudbø J, et al. J Clin Oncol. 2005 Mar 20;23(9):1927-33. doi: 10.1200/JCO.2005.03.172. J Clin Oncol. 2005. Retraction in: J Clin Oncol. 2006 Dec 10;24(35):5621. doi: 10.1200/JCO.2006.10.0057 PMID: 15774785 Retracted.

5

[Chemoprevention of oral cancer].

Sudbø J. Sudbø J. Tidsskr Nor Laegeforen. 2003 May 29;123(11):1518-21. Tidsskr Nor Laegeforen. 2003. Retraction in: Tidsskr Nor Laegeforen. 2006 Sep 7;126(17):2287. PMID: 12822012 Retracted. Review. Norwegian.

6

The influence of resection and aneuploidy on mortality in oral leukoplakia.

Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. Sudbø J, et al. N Engl J Med. 2004 Apr 1;350(14):1405-13. doi: 10.1056/NEJMoa033374. N Engl J Med. 2004. Retraction in: N Engl J Med. 2006 Nov 2;355(18):1927. doi: 10.1056/NEJMe068247 PMID: 15070790 Free article. Retracted.

7

Impact of genomic instability in risk assessment and chemoprevention of oral premalignancies.

Reith A, Sudbø J. Reith A, et al. Among authors: sudbo j. Int J Cancer. 2002 Sep 20;101(3):205-9. doi: 10.1002/ijc.10569. Int J Cancer. 2002. PMID: 12209969 Review.

8

DNA content as a prognostic marker in patients with oral leukoplakia.

Sudbø J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. Sudbø J, et al. N Engl J Med. 2001 Apr 26;344(17):1270-8. doi: 10.1056/NEJM200104263441702. N Engl J Med. 2001. Retraction in: N Engl J Med. 2006 Nov 2;355(18):1927. doi: 10.1056/NEJMe068247 PMID: 11320386 Free article. Retracted.

9

Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals.

Sudbø J, Reith A. Sudbø J, et al. J Oral Pathol Med. 2003 Feb;32(2):63-70. doi: 10.1034/j.1600-0714.2003.00054.x. J Oral Pathol Med. 2003. PMID: 12542827 Review.

10

Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions.

Sudbø J, Ristimäki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M. Sudbø J, et al. Oral Oncol. 2003 Jul;39(5):497-505. doi: 10.1016/s1368-8375(03)00012-5. Oral Oncol. 2003. Retraction in: Oral Oncol. 2007 Apr;43(4):420. doi: 10.1016/j.oraloncology.2007.01.003 PMID: 12747975 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters